Filtered By:
Drug: Vyvanse
This page shows you your search results in order of date.
Order by Relevance | Date
Total 47 results found since Jan 2013.
Delayed-Release ADHD Therapy Slightly Mitigates Slowed Growth in Kids
(MedPage Today) -- NASHVILLE -- Youth with attention-deficit/hyperactivity disorder (ADHD) saw mildly different growth trajectories with certain popular medications, researchers reported.
Compared with youth prescribed lisdexamfetamine dimesylate...
Source: MedPage Today Neurology - September 10, 2023 Category: Neurology Source Type: news
Generic Drugmakers Start Shipping Copies of ADHD Drug Generic Drugmakers Start Shipping Copies of ADHD Drug
Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical ' s drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States.Reuters Health Information
Source: Medscape Medical News Headlines - September 1, 2023 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
DUBLIN, Aug. 31, 2023 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, today announced that its Specialty Generics segment, operating as SpecGx LLC, received approval on August 25, ... Biopharmaceuticals, Generics, FDA Mallinckrodt, SpecGx, lisdexamfetamine, ADHD
Source: HSMN NewsFeed - August 31, 2023 Category: Pharmaceuticals Source Type: news
FDA OKs ADHD Generics; Flotation Therapy; Civilians Respond to Distress Calls
(MedPage Today) -- The FDA approved the first generic forms of lisdexamfetamine dimesylate (Vyvanse) capsules and chewables to treat attention deficit-hyperactivity disorder (ADHD) in patients 6 years and older, as well as moderate to severe binge...
Source: MedPage Today Psychiatry - August 30, 2023 Category: Psychiatry Source Type: news
Vaccine Skepticism Spreads to Pets; Generics for ADHD Approved; Malaria in Maryland
(MedPage Today) -- Note that some links may require registration or subscription.
Some dog owners questioned pet vaccines like rabies, survey data showed. (Vaccine)
The FDA approved multiple generics of lisdexamfetamine dimesylate to treat attention...
Source: MedPage Today Pediatrics - August 29, 2023 Category: Pediatrics Source Type: news
Generics of Vyvanse, Takeda's ADHD drug, get FDA green light
Takeda Pharmaceutical Company Limited just lost exclusivity on its ADHD drug.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 28, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
FDA Approves First Generics for Vyvanse
August 28, 2023 -- FDA has approved several first generics of Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets for attention-deficit/hyperactivity disorder (ADHD) in patients six years and older and moderate to severe binge-eating...
Source: Drugs.com - Daily MedNews - August 28, 2023 Category: General Medicine Source Type: news
Manufacturing delays hit Takeda's Vyvanse amid ADHD drug shortage
Takeda Pharmaceutical Company Limited is facing a manufacturing delay for its ADHD drug, Vyvanse, just as shortages for other ADHD drugs roil the country.
Source: bizjournals.com Health Care:Biotechnology headlines - June 15, 2023 Category: Biotechnology Authors: Rowan Walrath Source Type: news
ADHD Medication Might Help In Treating Amphetamine Addiction
A recent JAMA Psychiatry study found that an ADHD medicine called lisdexamfetamine reduced the risk of hospitalization due to amphetamine or methamphetamine addiciton by 18% and 14% for deaths caused by substance abuse disorders.
Source: Forbes.com Healthcare News - November 25, 2022 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news
Drug May Curb ‘ Sluggish ’ Thinking in Some Adults With ADHD
Lisdexamfetamine found to reduce symptoms of sluggish cognitive tempo in small group of adults with ADHD
Source: The Doctors Lounge - Psychiatry - July 2, 2021 Category: Psychiatry Tags: Pharmacy, Psychiatry, Journal, Source Type: news
Drug May Curb ' Sluggish ' Thinking in Some Adults With ADHD
THURSDAY, July 1, 2021 -- Lisdexamfetamine reduces symptoms of sluggish cognitive tempo (SCT) in adults with attention-deficit/hyperactivity disorder (ADHD), according to a study published online June 29 in the Journal of Clinical Psychiatry.
In a...
Source: Drugs.com - Pharma News - July 1, 2021 Category: Pharmaceuticals Source Type: news
Stimulant May Reduce ' Sluggish Cognitive Tempo ' in Adult ADHD Stimulant May Reduce ' Sluggish Cognitive Tempo ' in Adult ADHD
In addition to lower ADHD symptoms and better executive function, lisdexamfetamine is linked to reduced symptoms of sluggish cognitive tempo, new research suggests.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - July 1, 2021 Category: Neurology Tags: Psychiatry News Source Type: news
Medical News Today: What are the differences between Strattera and Vyvanse?
This article discusses their effects, risks, how to take them, and how to choose between the two.
Source: Health News from Medical News Today - August 1, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news
Medical News Today: Concerta vs. Vyvanse for ADHD
Concerta and Vyvanse are two stimulant medications that can help treat ADHD. In this article, learn about how they work, as well as their possible side effects.
Source: Health News from Medical News Today - July 17, 2019 Category: Consumer Health News Tags: ADHD / ADD Source Type: news
Medical News Today: What is the link between Vyvanse and hypersexuality?
Vyvanse is a brand of amphetamine that doctors may prescribe for ADHD or binge eating disorder (BED). Some research links amphetamine use to hypersexuality, and both ADHD and BED may also affect sexual function. Learn more about the symptoms of hypersexuality and the effects of the drug here.
Source: Health News from Medical News Today - June 27, 2019 Category: Consumer Health News Tags: Sexual Health / STDs Source Type: news
